Package 72673-091-14

{"route": ["ORAL"], "spl_id": "47d8769c-b294-65ab-e063-6394a90a8bff", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "upc": ["0372673091143"], "unii": ["8VZV102JFY"], "rxcui": ["310353"], "spl_set_id": ["2a3ba181-5baa-5942-e063-6294a90a82b2"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Zhejiang Poly Pharm. Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (72673-091-14)  / 35 mL in 1 BOTTLE", "package_ndc": "72673-091-14", "marketing_start_date": "20250401"}], "brand_name": "Fluconazole", "product_id": "72673-091_47d8769c-b294-65ab-e063-6394a90a8bff", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "72673-091", "generic_name": "Fluconazole", "labeler_name": "Zhejiang Poly Pharm. Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluconazole", "active_ingredients": [{"name": "FLUCONAZOLE", "strength": "40 mg/mL"}], "application_number": "ANDA215738", "marketing_category": "ANDA", "marketing_start_date": "20250401", "listing_expiration_date": "20271231"}